Potential prognosis and immunotherapy predictor TFAP2A in pan-cancer
Figure 8.The relationship between TFAP2A expression and immunotherapy efficiency. (A, B) Analysis of TFAP2A expression with the efficacy of blocking CTLA4 or PD1 in (A) BRCA and (B) COAD.